Cetera Investment Advisers’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.76M Buy
30,526
+4,275
+16% +$362K ﹤0.01% 2117
2026
Q1
$2.19M Buy
26,251
+308
+1% +$25.3K ﹤0.01% 2206
2025
Q4
$2.38M Buy
25,943
+1,305
+5% +$125K ﹤0.01% 2059
2025
Q3
$2.33M Buy
24,638
+16,757
+213% +$1.58M ﹤0.01% 2042
2025
Q2
$826K Buy
7,881
+2,621
+50% +$248K ﹤0.01% 2547
2025
Q1
$465K Buy
5,260
+1,688
+47% +$173K ﹤0.01% 2906
2024
Q4
$343K Buy
3,572
+225
+7% +$21K ﹤0.01% 2996
2024
Q3
$274K Sell
3,347
-3,106
-48% -$240K ﹤0.01% 3146
2024
Q2
$556K Buy
6,453
+3,044
+89% +$246K ﹤0.01% 2504
2024
Q1
$278K Buy
+3,409
New +$266K ﹤0.01% 3110

Other funds holding HQY

Cetera Investment Advisers's HQY Position: Q2 2026 in Review

Cetera Investment Advisers increased its HealthEquity (HQY) stake by 16% in Q2 2026, buying an estimated $362K and bringing the position to 30,526 shares worth $2.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2117.

Cetera Investment Advisers first reported a position in HQY in Q1 2024 and has held it in 10 quarters since. 500 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Cetera Investment Advisers held 30,526 shares of HealthEquity worth $2.76M as of Q2 2026.
  • Cetera Investment Advisers bought 4,275 HealthEquity shares in Q2 2026, an estimated $362K.
  • HealthEquity made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2117 holding.
  • Cetera Investment Advisers first reported a position in HealthEquity in Q1 2024 and has held it in 10 quarters since.
  • 500 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.